As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. | In a letter to the chair of the U.S.

Concerns are rising as Novo Nordisk's $16.5 billion bid to acquire Catalent faces scrutiny from the FTC. Critics argue the ...

Sen. Elizabeth Warren urges FTC to scrutinize Novo Nordisk's $16.5 billion acquisition of Catalent over concerns of increased ...

U.S. Senator Elizabeth Warren has asked antitrust regulators to closely scrutinize a $16.5 billion deal in which Novo Nordisk ...

On Monday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $60.61 which represents a slight increase of $0.02 or 0.03% from the prior close of $60.59. The stock opened at $60.53 and ...

Catalent Inc (CTLT) stock saw a decline, ending the day at $60.59 which represents a decrease of $-0.12 or -0.20% from the prior close of $60.71. The stock opened at $60.75 and touched a low of $60.5 ...

Hims & Hers' (HIMS) stock drop marks the latest overhang on a company that has more than doubled in value over the past 12 ...

Based on these metrics and many more, TAK holds a Value grade of A, while CTLT has a Value grade of C. Both TAK and CTLT are impressive stocks with solid earnings outlooks, but based on these ...

Based in Somerset, New Jersey, Catalent, Inc. (CTLT) develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products. Valued at a ...

Fintel reports that on September 24, 2024, Baird downgraded their outlook for Catalent (NYSE:CTLT) from Outperform to Neutral ...